| References: |
SR9243 is a new inhibitor of The nuclear receptor liver-X-receptor (LXR),inducing LXR-corepressor interaction. In cancer cells, SR9243 significantly inhibited the Warburg effect and lipogenesis by reducing glycolytic and lipogenic gene expression. SR9243 induced apoptosis in tumors without inducing weight loss, hepatotoxicity, or inflammation. For the detailed information of SR9243, the solubility of SR9243 in water, the solubility of SR9243 in DMSO, the solubility of SR9243 in PBS buffer, the animal experiment (test) of SR9243, the cell expriment (test) of SR9243, the in vivo, in vitro and clinical trial test of SR9243, the EC50, IC50,and affinity,of SR9243, For the detailed information of SR9243, the solubility of SR9243 in water, the solubility of SR9243 in DMSO, the solubility of SR9243 in PBS buffer, the animal experiment (test) of SR9243, the cell expriment (test) of SR9243, the in vivo, in vitro and clinical trial test of SR9243, the EC50, IC50,and affinity,of SR9243, Please contact DC Chemicals. |
